COVID-19 Respiratory Infection

Infectious Diseases
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ondine Biomedical
Ondine BiomedicalBC - Vancouver
1 program
Nasal PhotodisinfectionN/A1 trial
Active Trials
NCT05184205CompletedEst. May 2022
Abbott
AbbottABBOTT PARK, IL
1 program
The BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2.N/A1 trial
Active Trials
NCT04959760Completed263Est. Jan 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ondine BiomedicalNasal Photodisinfection
AbbottThe BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2.

Clinical Trials (2)

Total enrollment: 263 patients across 2 trials

NCT05184205Ondine BiomedicalNasal Photodisinfection

Photodynamic Therapy for COVID-19 Prevention

Start: Dec 2021Est. completion: May 2022
N/ACompleted
NCT04959760AbbottThe BinaxNOW™ Antibody Tests measure IgG antibodies against SARS-CoV-2.

BinaxNow COVID-19 IgG Rapid Test Device and Antibody Self Test

Start: Jun 2021Est. completion: Jan 2022263 patients
N/ACompleted

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space